Home Daily Stock Opinions and Ratings Extendicare Inc (EXE-T)

Trending stocks today

Chubb Limited Enbridge Loblaw Companies Ltd Methanex Corp H&R Real Estate Inv Trust Bank of Nova Scotia Telus Corp CAE Inc Block Inc Keycorp Prudential Financial Inc Nuvei Corp Toronto Dominion (TD) Fortinet Inc Manulife Financial Mainstreet Equity Corp Morguard Corporation Baytex Energy Corp Chord Energy Corp Athabasca Oil Sands Corp

Extendicare Inc (EXE-T)

152 watching

TSE:EXE

6.18
0.10 (1.64%) 1d
Mar 24, 2023, 8:00 pm
0
WATCH

Extendicare Inc(EXE-T)

26/01/2022
Extendicare Inc
He's looking at the space, which is attractive. Off the highs. Business is materially tougher, but we need it. Regulatory issues and scrutiny on EXE. Labour situation also difficult. Likes the price, but wants to see more on the business fundamentals.
other services
Ryan Bushell
$7.130
No
UnlockRating
DON'T BUY

Extendicare Inc(EXE-T)

12/01/2021
Extendicare Inc
There's always something that stops him from entering the seniors space in REITs: labour, regulator issues, though again demographics are a positive. That isn't a good enough, though. How will governments with huge debts supplement the entire seniors home space? However, EXE is cheap. This space is too volatile.
other services
Paul Gardner, CFA
$6.220
No
UnlockRating
DON'T BUY

Extendicare Inc(EXE-T)

28/04/2020
Extendicare Inc

How COVID will effect this industry, retirement homes? He owns Sienna instead. EXE is much more involved in government-funded LTCs. Along with Chartwell, these two companies are under government scrutiny, so they likely do a much better job than private LTCs. Good question how COVID will affect these homes: there may be increased costs to manage the LTCs, and he expects the government to do more oversight, particularly the incompetent LTCs. He prefers Sienna to EXE, because Sienna is a mix of LTCs and retirement homes, while Chartwell is mostly retirement homes, which has more upside but more competitive. Don't buy purely LTCs, like EXE.

other services
Stephen Takacsy, B. Eng, MBA
$6.750
No
UnlockRating
COMMENT

Extendicare Inc(EXE-T)

28/02/2020
Extendicare Inc

Extendicare has a better chart than Chartwell. It has a head-and-shoulder chart movement. If you take into account the general market sell-off, investors need to be forgiving.

other services
Keith Richards
$8.010
Unknown
UnlockRating
WATCH

Extendicare Inc(EXE-T)

24/02/2020
Extendicare Inc
He likes the aging demographics. It has been clawing itself back after problems in the US and high level debt. They are focused on their home care and supply chain businesses. They are trying to now go capital light. He is starting to look at it. It is trading at a discount, relative to peers.
other services
Stephen Takacsy, B. Eng, MBA
$8.550
Unknown
UnlockRating
BUY

Extendicare Inc(EXE-T)

20/02/2020
Extendicare Inc
The long-term care homes are all similar. Slow growers, good dividend yielders. Payouts are reasonable. Steady stream of income. Hasn't increased dividend for 3 years. Resistant to recessions. Labour and other costs are going up. Yield around 5%.
other services
Douglas Kee
$8.620
Unknown
UnlockRating
HOLD

Extendicare Inc(EXE-T)

23/12/2019
Extendicare Inc
A great demographic pick. He bought in at $7.01 in 2014 and bought in again at $6.62. He liked how they paid down debt and reduced operations in the US. He likes the dividend and thinks there is still good upside -- maybe another 50%. They have been growing organically and by takeover. He would like to see them pay down more debt. Yield 5%
other services
Benj Gallander
$8.450
Owned
UnlockRating
BUY on WEAKNESS

Extendicare Inc(EXE-T)

29/10/2019
Extendicare Inc
Enjoys a regulated revenue stream like other retirement homes, so it's fairly safe--but has only 2-5% growth. A long-term hold. Buy at $8, though you can sell it at $10.
other services
Bruce Campbell (1)
$9.020
Unknown
UnlockRating
DON'T BUY

Extendicare Inc(EXE-T)

21/10/2019
Extendicare Inc
Long term care. They have about 5% dividend but it is over 100% of cash flow. Sales are growing at 1.2%. The free cash flow yield is not there.
other services
Robert McWhirter
$0.000
Unknown
UnlockRating
DON'T BUY

Extendicare Inc(EXE-T)

23/08/2019
Extendicare Inc
Would avoid right now, with government regulation risk, and bad press. There's enough risk for negative press in healthcare stock.
other services
David Cockfield
$8.650
No
UnlockRating
BUY on WEAKNESS

Extendicare Inc(EXE-T)

31/07/2019
Extendicare Inc
Look at defensive stocks this time of year. EXE's moving averages are moving up. Add more at $8.60. It's overbought now, so expect consolidation first.
other services
Jon Vialoux
$8.960
Unknown
UnlockRating
HOLD

Extendicare Inc(EXE-T)

02/07/2019
Extendicare Inc
He bought more in December. They do have some debt -- a little higher than he likes. The payout ratio is such that the dividend is stable, but won't grow. The demographics are in their favour within senior housing. He is happy to keep holding it. Yield 5.7%
other services
Benj Gallander
$8.480
Owned
UnlockRating
BUY

Extendicare Inc(EXE-T)

23/04/2019
Extendicare Inc
The activist investor? The activist investor owns 9%. It's a leader in Canada. A great demographic play. Good dividend. This could hit $12-14. He's pleased that EXE has come to an agreement with the activist.
other services
Benj Gallander
$7.850
Owned
UnlockRating
DON'T BUY

Extendicare Inc(EXE-T)

20/03/2019
Extendicare Inc
This sector is almost as bad as airplanes, because there are government regulations and labour issues (minimum wage) and it's labour-intensive. Also. EXE missed their numbers and hasn't done much in two years. They blew their brains out in the U.S. where they got it. Also--his theory--technological advances and government incentives encourage seniors to stay in home and not enter nursing homes. The whole sector falls shorts.
other services
Paul Gardner, CFA
$7.480
No
UnlockRating
BUY

Extendicare Inc(EXE-T)

19/02/2019
Extendicare Inc
He bought it years ago. Pays 4-cents each month in dividends. He's doubled-down and averaged down. It doesn't have the normal upside for him, but it's a fine demographic play. People are getting older. He sees 50-100% upside. Safe to buy more here, but he wants them to pay down its debt more.
other services
Benj Gallander
$7.490
Owned
UnlockRating
Showing 1 to 15 of 230 entries
Next PageNext Page

Extendicare Inc(EXE-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Extendicare Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Extendicare Inc(EXE-T) Frequently Asked Questions

What is Extendicare Inc stock symbol?

Extendicare Inc is a Canadian stock, trading under the symbol EXE-T on the Toronto Stock Exchange (EXE-CT). It is usually referred to as TSX:EXE or EXE-T

Is Extendicare Inc a buy or a sell?

In the last year, there was no coverage of Extendicare Inc published on Stockchase.

Is Extendicare Inc a good investment or a top pick?

Extendicare Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Extendicare Inc.

Why is Extendicare Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Extendicare Inc worth watching?

0 stock analysts on Stockchase covered Extendicare Inc In the last year. It is a trending stock that is worth watching.

What is Extendicare Inc stock price?

On 2023-03-24, Extendicare Inc (EXE-T) stock closed at a price of $6.18.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Get Access To Watchlist

Latest Buy Signals

CPRX-QCatalyst Pharmaceuticals
Catalyst Pharmaceuticals
$15.21
-0.15 (-1.00%)
META-QMeta Platforms Inc / Facebook
Meta Platforms Inc / Facebook
$206.01
1.73 (0.83%)
PXD-NPioneer Natural Resources
Pioneer Natural Resources
$202.02
-2.30 (-1.15%)
PG-NProcter & Gamble
Procter & Gamble
$146.72
2.93 (1.96%)
MU-QMicron Technology
Micron Technology
$61.16
-0.18 (-0.30%)
Advertising

Today's Top Picks

ATH-TAthabasca Oil Sands Corp
Athabasca Oil Sands Corp
$2.93
0.02 (0.68%)
CHRD-QChord Energy Corp
Chord Energy Corp
$140.16
1.14 (0.81%)
BTE-TBaytex Energy Corp
Baytex Energy Corp
$4.63
0.04 (0.86%)
MRC-TMorguard Corporation
Morguard Corporation
$118.43
0.54 (0.45%)
MEQ-TMainstreet Equity Corp
Mainstreet Equity Corp
$127.22
0.72 (0.56%)

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

DAN-NDana Holding
Dana Holding
$18.79
0.25 (1.31%)
PBR-NPetroleo Bras Sa Petro
Petroleo Bras Sa Petro
$9.70
0.07 (0.72%)
ABX-NBarrick Gold Corp
Barrick Gold Corp
$17.57
-0.02 (-0.11%)
RH-NRH
RH
$259.73
-7.38 (-2.92%)
MKC-NMcCormick & Co
McCormick & Co
$72.87
1.67 (2.24%)

Most Recent Experts

Nuttall

Eric Nuttall

Ninepoint Partners

Stockchase

Stockchase Insights

5i Research

Cramer

Jim Cramer - Mad Money

CNBC

Madden

Brian Madden

First Avenue Investment Counsel

Panic-Proof (Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Advertising
Advertising
logoTop pickslogoStockslogoRecentlogoWatchlist
© Stockchase Inc.